Nonamyloidotic monoclonal immunoglobulin deposition disease. Light-chain, heavy-chain, and light- and heavy-chain deposition diseases.
Monoclonal gammopathy of renal significance from the perspective of nephrologists.
Park K, Kwon SH.
Blood Res. 2024 Aug 12;59(1):28. doi: 10.1007/s44313-024-00027-5.
Nonamyloidotic monoclonal immunoglobulin deposition disease. Light-chain, heavy-chain, and light- and heavy-chain deposition diseases.
Buxbaum J, Gallo G.
Hematol Oncol Clin North Am. 1999 Dec;13(6):1235-48. doi: 10.1016/s0889-8588(05)70123-4.
Non-Immunoglobulin Amyloidosis-Mediated Kidney Disease: Emerging Understanding of Underdiagnosed Entities.
Karam S, Kaushal A, Abu Amer N, Royal V, KItchlu A.
Adv Kidney Dis Health. 2024 Jul;31(4):334-345. doi: 10.1053/j.akdh.2024.02.001.
Proliferative glomerulonephritis with discrete deposition of monoclonal immunoglobulin gamma1 CH 2 heavy chain and kappa light chain: a new variant of monoclonal immunoglobulin deposition disease.
Komatsuda A, Ohtani H, Sawada K, Joh K, Wakui H.
Pathol Int. 2013 Jan;63(1):63-7. doi: 10.1111/pin.12024. Epub 2012 Dec 25.
Monoclonal gammopathy of renal significance: Spectrum of diseases and approach to a case.
Tewari R, Chatterjee T, Mendonca S, Dogra M, Pramanik SK, Yanamandra U.
Saudi J Kidney Dis Transpl. 2021 Mar-Apr;32(2):298-306. doi: 10.4103/1319-2442.335440.
Proliferative glomerulonephritis with monoclonal immunoglobulin deposits in a kidney allograft.
Batal I, Bijol V, Schlossman RL, Rennke HG.
Am J Kidney Dis. 2014 Feb;63(2):318-23. doi: 10.1053/j.ajkd.2013.07.015. Epub 2013 Sep 17.
Bortezomib produces high hematological response rates with prolonged renal survival in monoclonal immunoglobulin deposition disease.
Cohen C, Royer B, Javaugue V, Szalat R, El Karoui K, Caulier A, Knebelmann B, Jaccard A, Chevret S, Touchard G, Fermand JP, Arnulf B, Bridoux F.
Kidney Int. 2015 Nov;88(5):1135-43. doi: 10.1038/ki.2015.201. Epub 2015 Jul 15.
Usefulness and Limitations of Current Diagnostic Strategies for Pulmonary Mucosa-Associated Lymphoid Tissue Lymphoma: Lessons Learned From a Large Cohort.
Fraune C, Tazelaar HD, Butt YM, Smith ML, Larsen BT, Kelemen K.
Arch Pathol Lab Med. 2024 Apr 1;148(4):419-429. doi: 10.5858/arpa.2022-0521-OA.
